Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Teh‐Ling Takeshima"'
Autor:
Xiaoqing Zhang, Matias A. Bustos, Rebecca Gross, Romela Irene Ramos, Teh‐Ling Takeshima, Gordon B. Mills, Qiang Yu, Dave S. B. Hoon
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021)
Abstract Background 1q21.3 amplification, which is frequently observed in metastatic melanoma, is associated with cancer progression. Interleukin enhancer‐binding factor 2 (ILF2) is located in the 1q21.3 amplified region, but its functional role or
Externí odkaz:
https://doaj.org/article/93d85c4fa77046069f2a1780c2d10ba8
Autor:
Gordon B. Mills, Romela Irene Ramos, Dave S.B. Hoon, Teh-Ling Takeshima, Matias A. Bustos, Qiang Yu, Rebecca Gross, Xiaoqing Zhang
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021)
Clinical and Translational Medicine
Clinical and Translational Medicine
Background 1q21.3 amplification, which is frequently observed in metastatic melanoma, is associated with cancer progression. Interleukin enhancer‐binding factor 2 (ILF2) is located in the 1q21.3 amplified region, but its functional role or contribu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace6f18faa2f3d5689011ab9b6b2bcb0
https://doi.org/10.1002/ctm2.608
https://doi.org/10.1002/ctm2.608
Autor:
Xiaoqing Zhang, Matias A. Bustos, Rebecca Gross, Romela Irene Ramos, Teh-Ling Takeshima, Gordon B. Mills, Qiang Yu, Dave S. Hoon
Publikováno v:
Cancer Research. 82:3233-3233
Background: 1q21.3 amplification is frequently observed in metastatic melanoma. Interleukin enhancer-binding factor 2 (ILF2) is in the 1q21.3 amplified region. The functional role of ILF2 as well as its contribution in promoting an aggressive phenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2167ecd85a5a2367a78240367f80e424
https://doi.org/10.1158/1538-7445.am2022-3233
https://doi.org/10.1158/1538-7445.am2022-3233
Autor:
Teh-Ling Takeshima, Yoshiaki Shoji, Romela Irene Ramos, Matias A. Bustos, Rebecca Gentry, Yuuki Iida, Xiaoqing Zhang, Dave S.B. Hoon
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4691, p 4691 (2021)
Volume 13
Issue 18
Cancers, Vol 13, Iss 4691, p 4691 (2021)
Volume 13
Issue 18
The role of post-translational modifications (PTM) of the key epigenetic factor DNMT1 protein has not been well explored in cutaneous metastatic melanoma progression. The acetylated DNMT1 (ac-DNMT1) protein level was assessed using an anti-acetylated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08a22a93d895b72597acb519ad82562
https://doi.org/10.3390/cancers13184691
https://doi.org/10.3390/cancers13184691
Autor:
Steve R. Martinez, Teh Ling Takeshima, Vu D. Vu, Naoyuki Umetani, Dave S.B. Hoon, Minoru Kitago, Kazuo Koyanagi, He-Jing Wang, Christine Kuo, Robert Milford, Steven J. O'Day, Takuji Mori, Sandy L. Nguyen
Publikováno v:
Journal of Clinical Oncology. 23:9351-9358
Purpose Currently, no validated blood-based assays accurately predict treatment response or outcome in melanoma patients. We hypothesized that methylation of tumor-related genes detected in serum DNA could predict disease outcome and therapeutic resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d054f8929c797942cb353b73e94e639
https://doi.org/10.1200/jco.2005.02.9876
https://doi.org/10.1200/jco.2005.02.9876
Autor:
Sharon K. Huang, Christine T. Kuo, Teh-Ling Takeshima, Myung-Shin Sim, Yoshiki Takei, Kelly Chong, Donald L. Morton, Michelle W. Li, Sojun Hoshimoto, Dave S.B. Hoon
Publikováno v:
The Journal of investigative dermatology
Aberrations in the methylation status of noncoding genomic repeat DNA sequences and specific gene promoter region are important epigenetic events in melanoma progression. Promoter methylation status in long interspersed nucleotide element-1 (LINE-1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2edf18b0eae820a94b2c9794dcda6a9
https://pubmed.ncbi.nlm.nih.gov/22402438
https://pubmed.ncbi.nlm.nih.gov/22402438